← Back to Search

Behavioral Intervention

Narrative Intervention for Long COVID (NICO Trial)

N/A

Waitlist Available

Led By Rachel Johnson, PhD, LCSW

Research Sponsored by University of Colorado, Denver

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Diagnosed with Long COVID

Between the ages of 18-89 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up baseline and 3 months

Awards & highlights

NICO Trial Summary

This trial tests a new way to help people with long-term COVID-19 symptoms.

Who is the study for?

This trial is for adults aged 18-89 who have been diagnosed with Long COVID and can access email weekly. It's not suitable for those already participating in another research study.Check my eligibility

What is being tested?

The trial is testing a new approach called Narrative Intervention for Long COVID-19 (NICO), which aims to help people manage their long-term symptoms after a COVID infection.See study design

What are the potential side effects?

Since this intervention involves narrative techniques rather than medications, traditional side effects are not expected; however, the emotional or psychological impact will be monitored.

NICO Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

You have been diagnosed with Long COVID.

Select...

You are between 18 and 89 years old.

NICO Trial Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ baseline and 3 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~baseline and 3 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline and 3 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Personal Health Questionnarrie- 8 item (PHQ8)

Secondary outcome measures

Generalized Anxiety Disorder- 7 item (GAD7)

NICO Trial Design

1Treatment groups

Experimental Treatment

Group I: NICOExperimental Treatment1 Intervention

The NICO intervention includes components of narrative-informed interventions, brief solution-focused therapy, and medical social work case management to examine adjustment to illness for people living with Long COVID.

0 / 2Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of Colorado, DenverLead Sponsor

1,739 Previous Clinical Trials

2,150,133 Total Patients Enrolled

Rachel Johnson, PhD, LCSWPrincipal InvestigatorUniversity of Colorado, Denver

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are seniors being included in the recruitment for this trial?

"Entrants to this medical trial must be between 18 and 89 years old, in accordance with the listed criteria."

Answered by AI

Who has the requisite qualifications to participate in this clinical study?

"To be accepted to this trial, those suffering from long covid syndrome must fall within the ages of 18 and 89. Only 12 persons can join this research initiative."

Answered by AI

Are recruiters actively seeking out participants for this research project?

"Per information on clinicaltrials.gov, this medical trial has concluded its recruitment drive and is no longer seeking participants. The research was first posted in October 11th 2022 before being updated for the last time on October 18th 2023. Fortunately, there are 734 other studies currently enrolling patients at present."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Narrative Intervention for Long COVID-19 (NICO)

2022. "Narrative Intervention for Long COVID-19 (NICO)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06091293.

All > Survivor Corps